The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus: An NRG/Gynecologic Oncology Group study.
 
Carolyn K. McCourt
Consulting or Advisory Role - Genentech/Roche
 
Matthew Powell
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Speakers' Bureau - AstraZeneca; Roche/Genentech
 
Meaghan Elizabeth Tenney
No Relationships to Disclose
 
David M. Kushner
No Relationships to Disclose
 
Jacob Rotmensch
No Relationships to Disclose
 
James Erasmus Kendrick
No Relationships to Disclose
 
David Philip Warshal
Speakers' Bureau - AstraZeneca
 
Wei Deng
No Relationships to Disclose
 
Joel N. Saltzman
Stock and Other Ownership Interests - Foundation Medicine; novartis; Roche
 
Don S. Dizon
Consulting or Advisory Role - UpToDate
Research Funding - Aeterna Zentaris (Inst); GlaxoSmithKline (Inst)